The UCSF Fetal Treatment Center has been on the forefront of fetal treatment research since it's inception. The first open fetal surgery in the world was performed at UCSF over 2 decades ago and we continue to dedicate ourselves to research and innovation.
The UCSF Fetal Treatment Center, together with the Children's Hospital of Philadelphia and the University of Cincinnati, are embarking on a trial to determine whether steroids might be effective in preventing fetuses with large microcystic CCAM's from developing hydrops fetalis. This important study will help answer the question of whether administration of steroids to the mother, a benign treatment, is helpful to fetuses with large CCAM's whose previous prognosis was poor, and for whom the only previous treatment option was open maternal-fetal surgery.
You may be eligible to be considered for this clinical trial. For more information please visit Investigation of Prenatal Steroids for Treatment of Prenatally Diagnosed CCAMs.
Study analyzing fetal surgery and preterm labor.
Study analyzing the maternal risks of fetal surgical interventions.
Golombeck K, Ball RH, Lee H, Farrell JA, Farmer DL, Jacobs VR, Rosen MA, Filly RA, Harrison MR. Maternal morbidity after maternal-fetal surgery. Am J Obstet Gynecol. 2006 Mar;194(3):834-9.
Examination of a novel preventive “presealant” to protect amniotic membranes during fetal surgery.
Cortes RA, Wagner AJ, Lee H, Clifton MS, Grethel E, Yang SH, Ball R, Harrison MR. Pre-emptive placement of a presealant for amniotic access. Am J Obstet Gynecol. 2005 Sep;193(3 Pt 2):1197-203
Study evaluting recent advances in fetal treatment.